Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [398]

ASCO 2024: Sarcoma clinical trial reduces risk of relapse by 43%

ASCO 2024: Sarcoma clinical trial reduces risk of relapse by 43%

New resource for patients with intestinal cancer type most have never heard of before diagnosis

New resource for patients with intestinal cancer type most have never heard of before diagnosis

Kaposi sarcoma discovery could facilitate drug development

Kaposi sarcoma discovery could facilitate drug development

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial

FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive solid tumours

FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive...

Metabolic strategies to enhance CAR-T cell therapy

Metabolic strategies to enhance CAR-T cell therapy

AI tools tackle soft tissue sarcomas, identify new treatment strategies

AI tools tackle soft tissue sarcomas, identify new treatment strategies

Colorectal cancer gene implicated in broad range of solid tumours

Colorectal cancer gene implicated in broad range of solid tumours

Researchers unveil the origin of second paediatric cancers and chemotherapy-induced mutations in healthy tissues

Researchers unveil the origin of second paediatric cancers and chemotherapy-induced mutations in healthy tissues

New assay identifies clinically relevant gene fusions in paediatric tumours more accurately and efficiently

New assay identifies clinically relevant gene fusions in paediatric tumours more accurately and efficiently

More from ecancer